CDK2 and glioma: Additionally, LINC00958 regulates the miR-203/CDK2 axis in glioma (42), the miR-378a/IGF1R axis in bladder cancer (39), the miR-627/YBX2, and miR-185-5p/YWHAZ axes in oral squamous cell carcinoma (40), miR-5095/RRM2 in cervical cancer (18), miR-106a/AKT/mTOR in head and neck squamous cell carcinoma (36), and the miR-3619/HDGF axis in hepatocellular carcinoma (19).